Rockwell Medical (RMTI) Debt to Equity (2018 - 2025)
Rockwell Medical's Debt to Equity history spans 10 years, with the latest figure at $0.24 for Q4 2025.
- For Q4 2025, Debt to Equity fell 28.28% year-over-year to $0.24; the TTM value through Dec 2025 reached $0.24, down 28.28%, while the annual FY2025 figure was $0.24, 28.28% down from the prior year.
- Debt to Equity reached $0.24 in Q4 2025 per RMTI's latest filing, down from $0.28 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of $8.11 in Q4 2021 to a low of -$3.83 in Q1 2022.
- Average Debt to Equity over 5 years is $0.8, with a median of $0.51 recorded in 2023.
- Peak YoY movement for Debt to Equity: skyrocketed 1215.13% in 2021, then crashed 572.62% in 2022.
- A 5-year view of Debt to Equity shows it stood at $8.11 in 2021, then tumbled by 91.97% to $0.65 in 2022, then fell by 22.16% to $0.51 in 2023, then plummeted by 34.36% to $0.33 in 2024, then decreased by 28.28% to $0.24 in 2025.
- Per Business Quant, the three most recent readings for RMTI's Debt to Equity are $0.24 (Q4 2025), $0.28 (Q3 2025), and $0.37 (Q2 2025).